Security Snapshot

Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) Institutional Ownership

CUSIP: 42225T107

13F Institutional Holders and Ownership History from Q3 2019 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

125

Shares (Excl. Options)

52,246,466

Price

$1.99

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-3,431,560
Value change
-$5,215,585
Number of holders
125
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
73,911,438
SEC-reported price per share
$2.08
Insider filing price
$2.08
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 42225T107.
  • 125 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 128 to 125 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $70,715,015 to $103,969,268.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 125 institutions filings for Q2 2026.

Open SEC evidence

Security key

42225T107

Latest holder period

Q2 2026

13F holders

125

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
HCAT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 18% -6.9% $26,796,092 -$909,928 13,465,373 -3.3% Mathew P. Arens 12 Mar 2026
Stoney Lonesome HF LP 9.6% +11% $16,106,780 +$1,786,837 7,095,498 +12% COGHILL CLINT D 30 Jun 2026
Palogic Value Management, L.P. 6.7% $6,394,526 4,918,866 Palogic Value Management, LP 12 Jun 2026
Impax Asset Management Group plc 5.4% $7,960,000 4,000,000 Impax Asset Management Group plc 30 Jun 2026
Whetstone Capital Advisors, LLC 4.5% -46% $4,402,825 -$3,346,316 3,285,690 -43% Whetstone Capital Advisors, LLC 04 Jun 2026
BlackRock, Inc. 1.5% -80% $2,245,749 -$6,525,644 1,128,517 -74% BlackRock, Inc. 30 Jun 2026

As of 30 Jun 2026, 125 institutional investors reported holding 52,246,466 shares of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT). This represents 71% of the company’s total 73,911,438 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
65%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Light Asset Management, LLC 17% 12,810,861 -0.53% 1.5% $25,493,613
CDC Financial, Inc. 9.6% 7,092,698 +12% 11% $14,114,469
Palogic Value Management, L.P. 6.7% 4,922,442 +70% 3.5% $9,795,659
Impax Asset Management Group plc 5.4% 4,000,000 +45% 0.05% $7,960,000
Nepsis Inc. 4% 2,976,187 +59% 2% $5,922,612
VANGUARD CAPITAL MANAGEMENT LLC 4% 2,971,598 +3% 0% $5,913,480
BlackRock, Inc. 2.5% 1,836,373 -64% 0% $3,654,383
JANE STREET GROUP, LLC 1.4% 1,037,782 +3806% 0% $2,065,186
DIMENSIONAL FUND ADVISORS LP 1.2% 911,819 -26% 0% $1,814,353
GEODE CAPITAL MANAGEMENT, LLC 1.2% 891,357 -41% 0% $1,774,493
HighMark Wealth Management LLC 1.2% 871,082 -3.5% 0.58% $1,733,453
Caption Management, LLC 1% 773,650 +0.23% 0.05% $1,539,564
Mink Brook Asset Management LLC 1% 738,277 0.65% $1,469,171
Prescott Group Capital Management, L.L.C. 0.96% 710,803 0% 0.12% $1,414,498
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 615,504 +1.4% 0% $1,224,853
HRT FINANCIAL LP 0.77% 572,215 +135% 0% $1,138,000
MILLENNIUM MANAGEMENT LLC 0.7% 516,083 0% $1,027,005
GOLDMAN SACHS GROUP INC 0.65% 480,970 +24% 0% $957,130
VANGUARD FIDUCIARY TRUST CO 0.63% 463,005 +4.4% 0% $921,380
CITADEL ADVISORS LLC 0.61% 453,214 0% $901,896
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.59% 437,227 +439% 0% $870,082
FMR LLC 0.56% 410,637 +12% 0% $817,166
HSBC HOLDINGS PLC 0.55% 408,634 +313% 0% $809,095
Squarepoint Ops LLC 0.54% 400,210 +1215% 0% $796,418
AQR CAPITAL MANAGEMENT LLC 0.51% 376,586 -31% 0% $749,406

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Latest
Q2 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 52,246,466 $103,969,268 -$5,215,585 $1.99 125
2026 Q1 55,745,714 $70,715,015 -$2,578,135 $1.27 128
2025 Q4 55,255,926 $132,053,597 -$6,516,575 $2.39 136
2025 Q3 54,134,724 $154,287,158 -$4,573,641 $2.85 142
2025 Q2 54,164,187 $204,239,601 +$2,031,442 $3.77 144
2025 Q1 53,179,756 $240,899,632 -$15,089,868 $4.53 163
2024 Q4 51,714,283 $365,529,299 +$10,713,924 $7.07 164
2024 Q3 52,033,442 $423,157,153 +$11,669,218 $8.14 158
2024 Q2 50,973,377 $325,694,724 +$3,633,936 $6.39 159
2024 Q1 50,065,423 $376,991,717 +$764,949 $7.53 170
2023 Q4 49,726,125 $460,463,313 +$1,604,271 $9.26 165
2023 Q3 49,374,836 $499,663,628 +$2,966,722 $10.12 155
2023 Q2 48,824,578 $610,231,678 +$4,102,989 $12.50 152
2023 Q1 48,547,295 $566,456,324 -$1,965,202 $11.67 158
2022 Q4 48,846,831 $519,237,991 -$2,727,981 $10.63 164
2022 Q3 49,010,406 $475,542,822 -$73,165,265 $9.70 163
2022 Q2 52,853,537 $766,547,805 -$46,880,972 $14.49 170
2022 Q1 53,285,286 $1,391,839,063 -$65,374,738 $26.13 180
2021 Q4 55,189,855 $2,186,203,412 +$48,206,866 $39.62 178
2021 Q3 53,304,379 $2,668,051,943 +$252,469,889 $50.01 198
2021 Q2 48,146,470 $2,673,141,898 +$252,885,500 $55.51 197
2021 Q1 43,869,916 $2,051,715,173 +$163,395,411 $46.77 187
2020 Q4 40,380,352 $1,757,762,073 +$87,929,967 $43.53 168
2020 Q3 40,018,208 $1,463,894,335 +$230,365,790 $36.60 138
2020 Q2 33,977,864 $991,115,334 +$212,900,758 $29.17 127
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .